Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Clinical trial NCT03596450 · COMPLETED
Trial details
- NCT number
- NCT03596450
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2022-06-09
- Enrollment
- 1278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.